Crescent Grove Advisors, LLC Moderna, Inc. Transaction History

Crescent Grove Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$135.66 - $197.02 $10,038 - $14,579	-74 Reduced 5.34%	1,312 $201,000
Q4 2022 Jan 12, 2023	SELL	$118.38 - $210.04 $59,190 - $105,020	-500 Reduced 26.51%	1,386 $0
Q3 2022 Nov 08, 2022	BUY	$118.07 - $194.18 $41,324 - $67,963	350 Added 22.79%	1,886 $223,000
Q2 2022 Jul 20, 2022	BUY	$117.13 - $176.59 $17,569 - $26,488	150 Added 10.82%	1,536 $219,000
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $175,273 - $325,779	1,386 New	1,386 $239,000
Q4 2021 Jan 24, 2022	SELL	$225.82 - $368.51 $203,689 - $332,396	-902 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$221.9 - $484.47 $4,881 - $10,658	22 Added 2.5%	902 $347,000
Q2 2021 Jul 26, 2021	BUY	$129.91 - $234.98 $114,320 - $206,782	880 New	880 $207,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.